Response to long-term deferoxamine therapy in thalassemia

This publication has 19 references indexed in Scilit:

• DECREASING IRON STORES DURING INTENSIVE CHELATION THERAPY *
  Annals of the New York Academy of Sciences, 1980
• IMPROVEMENT IN IRON STATUS AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD WITH LONG-TERM SUBCUTANEOUS DESFERRIOXAMINE
  The Lancet, 1979
• Iron Absorption in the Thalassemia Syndromes and Its Inhibition by Tea
  New England Journal of Medicine, 1979
• Iron chelation therapy with deferoxamine in Cooley anemia
  The Journal of Pediatrics, 1978
• Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload
  New England Journal of Medicine, 1977
• Measurement of serum ferritin by a 2-site immunoradiometric assay
  Analytical Biochemistry, 1974
• Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress
  BMJ, 1974
• Deferoxamine mesylate (Desferal mesylate); A specific iron‐chelating agent for treating acute iron intoxication
  Clinical Pharmacology & Therapeutics, 1969
• Effects of Iron Overload on Ascorbic Acid Metabolism
  BMJ, 1968
• Treatment of Primary and Secondary Hemochromatosis and Acute Iron Poisoning with a New, Potent Iron-Eliminating Agent (Desferrioxamine-B)
  New England Journal of Medicine, 1963